U.S. markets closed
  • S&P Futures

    4,200.25
    -22.75 (-0.54%)
     
  • Dow Futures

    33,855.00
    -162.00 (-0.48%)
     
  • Nasdaq Futures

    13,877.00
    -104.25 (-0.75%)
     
  • Russell 2000 Futures

    2,291.70
    -18.40 (-0.80%)
     
  • Crude Oil

    71.54
    -0.61 (-0.85%)
     
  • Gold

    1,817.90
    -43.50 (-2.34%)
     
  • Silver

    27.25
    -0.56 (-2.00%)
     
  • EUR/USD

    1.1990
    -0.0010 (-0.08%)
     
  • 10-Yr Bond

    1.5690
    +0.0700 (+4.67%)
     
  • Vix

    18.15
    +1.13 (+6.64%)
     
  • GBP/USD

    1.3980
    -0.0007 (-0.05%)
     
  • USD/JPY

    110.7470
    +0.1340 (+0.12%)
     
  • BTC-USD

    38,602.70
    -1,399.14 (-3.50%)
     
  • CMC Crypto 200

    956.75
    -35.73 (-3.60%)
     
  • FTSE 100

    7,184.95
    +12.47 (+0.17%)
     
  • Nikkei 225

    28,987.82
    -303.19 (-1.04%)
     

VYNE Therapeutics Inc. (VYNE) Q1 2021 Earnings Call Transcript

·29 min read
VYNE Therapeutics Inc. (VYNE) Q1 2021 Earnings Call Transcript

Good morning, and welcome to the VYNE Therapeutics conference call to discuss the first-quarter 2021 financial results and update. Before we begin formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve risks, uncertainties and assumptions that are difficult to predict including statements, forecasts and observations regarding future financial operating performance, impacts of the COVID-19 pandemic online and observations regarding ongoing operating expenses and net revenue. Words that expect to reflect optimism, satisfaction with current progress, prospects or projections, as well as words such as believe, intend, expect, plan, anticipate and similar variations identify forward-looking statements, but their absence does not mean that a statement is not forward-looking.